Group 1 - The core viewpoint of the news is the performance and financial metrics of Zhongtung High-tech Materials Co., Ltd., which saw a stock price increase of 5.42% to 50.19 CNY per share, with a trading volume of 928 million CNY and a market capitalization of 114.36 billion CNY [1] - Zhongtung High-tech specializes in the research, development, production, sales, and trade of hard alloys and rare metals such as tungsten, molybdenum, tantalum, and niobium, with its main revenue sources being: 34.74% from ore and powder products, 23.13% from other hard alloys, 21.68% from cutting tools, 16.23% from refractory metals, and 4.22% from trade and equipment [1] Group 2 - From the perspective of fund holdings, Huashang Fund has a significant position in Zhongtung High-tech, with its Huashang New Vitality Mixed Fund (001933) holding 160,000 shares, representing 3.88% of the fund's net value, making it the ninth largest holding [2] - The Huashang New Vitality Mixed Fund has achieved a year-to-date return of 9.33%, ranking 1803 out of 8884 in its category, and a one-year return of 71.97%, ranking 470 out of 8127 [2]

Core Viewpoint - Saintno Bio (688117.SH) reported a decline in institutional ownership in its half-year report for 2025, with a total of 70.23 million shares held by eight institutional investors, representing 44.62% of the total share capital, down 4.62 percentage points from the previous quarter [1] Institutional Ownership - As of August 14, 2025, eight institutional investors disclosed their holdings in Saintno Bio, totaling 70.23 million shares, which is 44.62% of the company's total equity [1] - The institutional investors include Sichuan Sino Investment Co., Ltd., Sichuan Development Securities Investment Fund Management Co., Ltd., Lepu Medical Technology (Beijing) Co., Ltd., and several mutual funds [1] - Compared to the previous quarter, the total institutional ownership percentage decreased by 4.62 percentage points [1] Public Fund Disclosures - Four new public funds disclosed their holdings this period, including Huashang Intelligent Life Flexible Allocation Mixed A, Huashang Emerging Vitality Mixed, Huashang Core Growth One-Year Holding Mixed A, and Huashang Excellent Growth One-Year Holding Mixed A [1] - Seven public funds that were previously disclosed did not report this quarter, including Yuanxin Yongfeng Ju You A, China Merchants Medical Health Industry Stock, and several others [1]